Circulating tumor DNA (ctDNA) in fluids has gained attention because ctDNA seems to
identify tumor-specific abnormalities, which could be used for diagnosis, follow-up of …

In recent years, the introduction of new molecular techniques in experimental and clinical
settings has allowed researchers and clinicians to propose circulating-tumor DNA (ctDNA) …

Lung cancer is the leading cause of cancer-related deaths worldwide. As the most prevalent
molecular mutation subtypes in non-small cell lung cancer (NSCLC), EGFR-TKIs are …

Background Lung cancer is one of the leading causes of death in the world and the
deadliest of all cancers. Apoptosis is a key pathway in regulating the cell growth rate …

Liquid biopsy is a valuable precision oncology tool that is increasingly used as a non-
invasive approach to identify biomarkers, detect resistance mutations, monitor disease …

Liquid biopsy, which is a minimally invasive procedure as an alternative to tissue biopsy,
has been introduced as a new diagnostic/prognostic measure. By screening disease-related …

Background Anomalous expression of glucose transporters (GLUTs) has been observed in
a variety of tumor tissues. Although GLUT factors have been shown to have prognostic value …

Background Circulating tumor DNA (ctDNA) analysis has been applied in cancer
diagnostics including lung cancer. Specifically for the early detection purpose, various …

Simple Summary Most solid tumors share mutations in TP53 that is thus considered one of
the main cancer driver genes. Mutations in TP53 occur very early during tumor development …

Breast cancer (BC) represents the most commonly diagnosed cancer among females
worldwide. Although targeted therapy has greatly improved the efficacy of treating BC, a …